Prognostic factors in patients with colorectal cancer receiving adjuvant chemotherapy or chemoradiotherapyA pooled analysis of two randomized studies

被引：5
|
作者：
Aristotle Bamias
George Basdanis
Ioannis Xanthakis
Nicholas Pavlidis
George Fountzilas
机构：
[1] University of Athens,Dept of Clinical Therapeutics, Medical School
[2] Aristotle University of Thessaloniki,Medical School
[3] Ioannina University,Medical School
来源：
International Journal of Gastrointestinal Cancer | 2005年 / 36卷 / 1期
关键词：
Adjuvant therapy; colorectal cancer; prognostic factors; 5-FU;
D O I：
10.1385/IJGC:36:1:029
中图分类号：
学科分类号：
摘要：
Background. Although the TNM system is useful in predicting survival in resected colorectal cancer, heterogeneity within the same stages regarding prognosis exists. We are presenting a pooled analysis of prognostic factors from two randomized studies of adjuvant treatment conducted by the Hellenic Cooperative Oncology Group.
引用
收藏
页码：29 / 38
页数：9
相关论文
共 50 条
  • [31] Prognostic factors for recurrence in stage II and III gastric cancer patients receiving a curative resection and postoperative adjuvant chemotherapy
    Tsujinaka, T
    Shiozaki, H
    Yano, M
    Kikkawa, N
    Takami, M
    Monden, M
    ONCOLOGY REPORTS, 2001, 8 (01) : 33 - 38
  • [32] Timing of Adjuvant Chemotherapy in Colorectal Cancer Patients
    Baek, Moo-Jun
    ANNALS OF COLOPROCTOLOGY, 2013, 29 (04) : 138 - 138
  • [33] Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients
    Glimelius, Bengt
    Osterman, Erik
    CANCERS, 2020, 12 (08) : 1 - 22
  • [34] Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy
    D-W Lee
    S-W Han
    H J Lee
    Y-Y Rhee
    J M Bae
    N-Y Cho
    K-H Lee
    T-Y Kim
    D-Y Oh
    S-A Im
    Y-J Bang
    S-Y Jeong
    K J Park
    J-G Park
    G H Kang
    T-Y Kim
    British Journal of Cancer, 2013, 108 : 1978 - 1984
  • [35] Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy
    Lee, D-W
    Han, S-W
    Lee, H. J.
    Rhee, Y-Y
    Bae, J. M.
    Cho, N-Y
    Lee, K-H
    Kim, T-Y
    Oh, D-Y
    Im, S-A
    Bang, Y-J
    Jeong, S-Y
    Park, K. J.
    Park, J-G
    Kang, G. H.
    Kim, T-Y
    BRITISH JOURNAL OF CANCER, 2013, 108 (10) : 1978 - 1984
  • [36] Analysis of prognostic factors in different grades of histologic differentiation in colorectal cancer patients receiving preoperative neoadjuvant chemotherapy and establishment of prognostic nomograms for moderately differentiated grade
    Xiagang Luo
    Yimin E
    Jie Wu
    Chen Lu
    Jianping Zhang
    International Journal of Colorectal Disease, 38
  • [37] Analysis of prognostic factors in different grades of histologic differentiation in colorectal cancer patients receiving preoperative neoadjuvant chemotherapy and establishment of prognostic nomograms for moderately differentiated grade
    Luo, Xiagang
    Yimin, E.
    Wu, Jie
    Lu, Chen
    Zhang, Jianping
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2023, 38 (01)
  • [38] Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical Trials
    Zhu, Lizhen
    Dong, Caixia
    Cao, Ying
    Fang, Xuefeng
    Zhong, Chenhan
    Li, Dan
    Yuan, Ying
    PLOS ONE, 2016, 11 (05):
  • [39] Efficacy of Adjuvant Chemotherapy and Prognostic Factors for Patients with Extrahepatic Bile Duct Cancer
    Lee, Hee Seung
    Lee, Sang Hoon
    Roh, Yun Ho
    Chung, Moon Jae
    Park, Jeong Youp
    Park, Seung Woo
    Song, Si Young
    Chung, Jae Bok
    Bang, Seungmin
    CHEMOTHERAPY, 2015, 61 (03) : 152 - 158
  • [40] Pre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy
    Ceze, N.
    Thibault, G.
    Goujon, G.
    Viguier, J.
    Watier, H.
    Dorval, E.
    Lecomte, T.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (05) : 1305 - 1313
12345